Table 2. Proportion of the 1854 participants by number of CD and by individual CD status at baseline and follow-up and the number and type of CD developed during the 7.8 years of follow-up.
| CD count (n(% of column)) | |||
| Baseline | Follow-up | New CD developed | |
| CD count | 2087 | 3880 | 1793 |
| Number of CD | |||
| 0 | 555 (30) | 164(9) | |
| 1 | 714 (38) | 496(27) | |
| 2 | 428 (23) | 578 (31) | |
| 3 | 120 (7) | 338 (18) | |
| 4+ | 37(2) | 278 (15) | |
| Multimorbidity (2+) | 585 (32) | 1194 (64) | |
| Individual CD | |||
| Asthma | 219 (12) | 463 (25) | 244 (13) |
| COPD | 67 (4) | 293 (16) | 226 (12) |
| Mood and anxiety disorders | 176 (10) | 385 (21) | 209 (11) |
| Other mental disorders | 120 (6) | 290 (16) | 170 (9) |
| Hypercholesterolemia | 756 (41) | 1178 (64) | 422 (23) |
| Diabetes | 127 (7) | 228 (12) | 101 (5) |
| CVD | 96 (5) | 163 (9) | 67 (4) |
| Hypertension | 526 (28) | 880 (48) | 354 (19) |
COPD: Chronic obstructive pulmonary disease and CVD: Cardiovascular disease and stroke.